Anthracycline antibiotics as cellular disruptors: insights into anthracycline-induced cardiomyopathy.
D000199:Actins / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D009202:Cardiomyopathies / Q000139:chemically induced; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D004285:Dogs; D004317:Doxorubicin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits
D000199:Actins; D012313:RNA; D004317:Doxorubicin; D004247:DNA; D002118:Calcium